Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-883P is classified as a pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNA itself is an essential non-coding RNA component of the spliceosome, which is involved in the removal of introns from pre-mRNA during RNA splicing in eukaryotic nuclei[5]. However, RNU6-883P is a non-functional "pseudogene" copy of this snRNA, likely formed through retrotransposon activity and not thought to be transcribed into a functional RNA molecule[7]. Pseudogenes like RNU6-883P are common in the human genome and, while most are non-functional remnants, some can participate in regulatory processes or serve as evolutionary markers, but no direct evidence for such functions specific to RNU6-883P exists[2][7][5]. This is not a receptor, enzyme, or any classical therapeutic target; it is a non-coding RNA pseudogene. There is no evidence that RNU6-883P has a direct biological function, disease relevance, or drug interactions. Pseudogenes can have rare regulatory roles but this is not generally established for the vast majority, including this one[2][7]. The name is sometimes misspelled or confused with similar-numbered U6 snRNA pseudogenes (such as RNU6-833P or RNU6-83P)[1][4], but the core category and function are unchanged. In conclusion, RNU6-883P is a non-coding RNA pseudogene unrelated to therapeutic target classes such as receptors or enzymes, and is not generally relevant as a drug target, biomarker, or disease gene in current biomedical knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 883, pseudogene (RNU6-883P).